Intellia Therapeutics, Inc. (NTLA)
12.26
+0.14
(+1.16%)
USD |
NASDAQ |
Oct 02, 16:00
12.16
-0.10
(-0.82%)
After-Hours: 20:00
Intellia Therapeutics Max Drawdown (5Y) : 96.45% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 96.45% |
| August 31, 2026 | 96.45% |
| July 31, 2026 | 96.45% |
| June 30, 2026 | 96.45% |
| May 31, 2026 | 96.45% |
| April 30, 2026 | 96.45% |
| March 31, 2026 | 96.45% |
| February 28, 2026 | 96.45% |
| January 31, 2026 | 96.45% |
| December 31, 2025 | 96.45% |
| November 30, 2025 | 96.45% |
| October 31, 2025 | 96.45% |
| September 30, 2025 | 96.45% |
| August 31, 2025 | 96.45% |
| July 31, 2025 | 96.45% |
| June 30, 2025 | 96.45% |
| May 31, 2025 | 96.45% |
| April 30, 2025 | 96.45% |
| March 31, 2025 | 95.98% |
| February 28, 2025 | 94.79% |
| January 31, 2025 | 94.67% |
| December 31, 2024 | 93.55% |
| November 30, 2024 | 92.58% |
| October 31, 2024 | 91.96% |
| September 30, 2024 | 88.84% |
| Date | Value |
|---|---|
| August 31, 2024 | 88.68% |
| July 31, 2024 | 88.68% |
| June 30, 2024 | 88.68% |
| May 31, 2024 | 88.68% |
| April 30, 2024 | 88.68% |
| March 31, 2024 | 86.90% |
| February 29, 2024 | 86.90% |
| January 31, 2024 | 86.90% |
| December 31, 2023 | 86.90% |
| November 30, 2023 | 86.90% |
| October 31, 2023 | 86.90% |
| September 30, 2023 | 82.11% |
| August 31, 2023 | 81.21% |
| July 31, 2023 | 81.21% |
| June 30, 2023 | 81.21% |
| May 31, 2023 | 81.21% |
| April 30, 2023 | 81.21% |
| March 31, 2023 | 81.21% |
| February 28, 2023 | 81.21% |
| January 31, 2023 | 81.21% |
| December 31, 2022 | 81.21% |
| November 30, 2022 | 78.23% |
| October 31, 2022 | 78.23% |
| September 30, 2022 | 78.23% |
| August 31, 2022 | 78.23% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Beam Therapeutics, Inc. | 89.12% |
| Twist Bioscience Corp. | 94.48% |
| Prime Medicine, Inc. | -- |
| Moderna, Inc. | 95.38% |
| Q32 Bio, Inc. | 99.58% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -60.04 |
| Beta (5Y) | 1.801 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 76.17% |
| Historical Sharpe Ratio (5Y) | -0.5517 |
| Historical Sortino (5Y) | -1.021 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.17% |